🔴 Neumora Therapeutics is trading 5% down today as hotter-than-expected August producer inflation weighs on markets

Neumora Therapeutics is trading 5% down at $1.14 as broader markets weaken following hotter-than-expected August producer inflation.

• The S&P 500, Nasdaq Composite, and Dow Jones are each down more than 0.5%, pressuring rate-sensitive and speculative stocks.
• No clear company-specific announcement, earnings update, regulatory development, or analyst action dated September 10, 2026 explains the decline.
• Recent company news remains focused on pipeline progress.